ONCT-534 Earns FDA Fast Track Designa... - Advanced Prostate...

Advanced Prostate Cancer

22,290 members27,988 posts

ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC

Maxone73 profile image
5 Replies

ONCT-534 recruiting

cancernetwork.com/view/onct...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
5 Replies
kainasar profile image
kainasar

Thanks. Their is still hope.

Scout4answers profile image
Scout4answers

According to findings from preclinical studies, the agent has demonstrated activity in prostate cancer models with and without AR mutations.

Does not say what the basis for fast track is. Could it be more than mouse models?

Maxone73 profile image
Maxone73 in reply toScout4answers

it's for investigational drugs development, I thought it would happen after an incredibly promising start of phase 1, but it seems that the potential and the fact that it would be a lifesaver can be enough

from what I read they will sun a phase 1/2 instead of two separate phases

Maxone73 profile image
Maxone73 in reply toScout4answers

ah here you go: onclive.com/view/fda-allows...

they were already in phase 1/2 in august

j-o-h-n profile image
j-o-h-n

Good Luck, Good Health and Good Humor.

j-o-h-n Monday 10/30/2023 7:45 PM DST

My work of art............Little bastards having fun with my body.

Not what you're looking for?

You may also like...

FDA Fast Track Designation for 225Ac-FL-020 for mCRPCa

Another weapon, from Germany this time....ahhhh zee germanz! Actinium strikes again! Phase 1 trial...
Maxone73 profile image

Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage...
God_Loves_Me profile image

Olaparib Combo Improves PFS/Responses in Metastatic CRPC - from ASCO GU2024

I am not sure, they always mix BTCA 1/2 and ATM, but maybe I can find the data for ATM only...but...
Maxone73 profile image

Clarity Pharmaceuticals gains FDA fast-track status for advanced prostate cancer 64Cu-SAR-bisPSMA imaging -hopefully soon also for treatment

As you know by now, I am following this technology pretty closely as it is very promising and their...
Maxone73 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.